Bombesin receptor subtype-3 (BRS-3), a novel candidate as therapeutic molecular target in obesity and diabetes

  1. Ramos-álvarez, I.
  2. Martín-Duce, A.
  3. Moreno-Villegas, Z.
  4. Sanz, R.
  5. Aparicio, C.
  6. Portal-Núñez, S.
  7. Mantey, S.A.
  8. Jensen, R.T.
  9. González, N.
Revue:
Molecular and Cellular Endocrinology

ISSN: 0303-7207,  1872-8057

Année de publication: 2013

Volumen: 367

Número: 1-2

Pages: 109-115

Type: Article

DOI: 10.1016/J.MCE.2012.12.025 GOOGLE SCHOLAR

Objectifs de Développement Durable

La source de données: Scopus